Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Gene-edited meat in Canada: To label or not to label?

The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...
Donga Science

Gene Editing Could Redefine Human Reproduction, Raising Ethical Questions

After the advent of gene-editing technology, if it can lead to disease treatment, the question naturally moves to the next ...

Eli Lilly (LLY) taps gene-editing technology to target hearing loss, Reuters reports

Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Stocks to Buy for the Long Term. According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to ...
GEN

Gene Editing Marches On Despite Missed Beats

Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.
Nasdaq

The Democratization of Gene-Editing and the Odin DIY Kit

We’ve seen gene-editing in works of fiction make wonders for humans and the environment, from creating “healing factors” in humans, to transforming agriculture for greater sustainability. Genetic ...
CounterPunch

Human Gene Editing and the CRISPR Revolution

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...